Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Guido Tricot

Concepts (550)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Multiple Myeloma
148
2025
2999
8.940
Why?
Hematopoietic Stem Cell Transplantation
28
2024
597
3.440
Why?
Pyrazines
20
2023
188
2.540
Why?
Antineoplastic Combined Chemotherapy Protocols
35
2024
1020
2.410
Why?
Boronic Acids
19
2014
181
2.350
Why?
Thalidomide
28
2023
377
2.340
Why?
Transplantation, Autologous
30
2024
480
1.870
Why?
Antineoplastic Agents
30
2020
1214
1.860
Why?
Transplantation Conditioning
9
2019
92
1.400
Why?
Drug Resistance, Neoplasm
17
2020
324
1.390
Why?
Paraproteinemias
8
2018
72
1.220
Why?
Humans
158
2025
52114
1.150
Why?
Neoplastic Stem Cells
5
2020
90
1.140
Why?
Protease Inhibitors
6
2011
59
1.020
Why?
Venous Thrombosis
7
2009
90
0.990
Why?
Melphalan
16
2023
178
0.960
Why?
Stem Cell Transplantation
13
2023
186
0.950
Why?
Angiogenesis Inhibitors
9
2009
184
0.950
Why?
Plasma Cells
12
2025
234
0.940
Why?
Aged
59
2025
10142
0.930
Why?
Prognosis
34
2025
2093
0.920
Why?
Gene Expression Regulation, Neoplastic
13
2020
853
0.900
Why?
Hematopoietic Stem Cell Mobilization
5
2014
60
0.890
Why?
Middle Aged
61
2025
13028
0.870
Why?
Alkaline Phosphatase
5
2011
92
0.810
Why?
Busulfan
3
2019
17
0.800
Why?
Treatment Outcome
39
2022
5456
0.750
Why?
Dexamethasone
16
2024
435
0.720
Why?
Male
69
2025
26652
0.680
Why?
Female
65
2025
28055
0.640
Why?
Chromosome Aberrations
9
2008
295
0.630
Why?
Thromboembolism
3
2009
49
0.630
Why?
Neoplasm Proteins
6
2021
328
0.600
Why?
Chromosomes, Human, Pair 13
6
2008
38
0.570
Why?
Gene Expression Profiling
19
2025
1101
0.560
Why?
Disease-Free Survival
14
2019
462
0.550
Why?
Immunoglobulin Light Chains
3
2016
90
0.540
Why?
Survival Rate
18
2019
945
0.540
Why?
Bone Remodeling
2
2010
154
0.540
Why?
Anticoagulants
5
2009
276
0.530
Why?
Blood Transfusion
1
2018
129
0.530
Why?
Monoclonal Gammopathy of Undetermined Significance
5
2025
120
0.530
Why?
Immunologic Factors
5
2012
117
0.520
Why?
Cell Line, Tumor
18
2023
1418
0.510
Why?
Follow-Up Studies
21
2024
2282
0.490
Why?
Receptors, Retinoic Acid
2
2013
22
0.490
Why?
Adult
39
2025
14095
0.480
Why?
Antineoplastic Agents, Alkylating
7
2008
77
0.480
Why?
Proteasome Inhibitors
6
2018
101
0.480
Why?
IMP Dehydrogenase
2
2006
3
0.470
Why?
Clinical Trials as Topic
9
2022
463
0.470
Why?
Mycophenolic Acid
2
2006
19
0.470
Why?
Combined Modality Therapy
13
2008
634
0.460
Why?
Disease Progression
13
2025
866
0.450
Why?
Cell Proliferation
15
2020
1017
0.450
Why?
Recurrence
16
2018
680
0.450
Why?
Retrospective Studies
19
2025
6610
0.440
Why?
Antigens, Neoplasm
5
2007
146
0.440
Why?
Apoptosis
9
2019
1117
0.440
Why?
Antibodies, Monoclonal
3
2015
475
0.430
Why?
Up-Regulation
5
2020
459
0.430
Why?
Osteogenesis
3
2012
365
0.420
Why?
Animals
30
2024
13332
0.420
Why?
Venous Thromboembolism
3
2011
75
0.420
Why?
Survival Analysis
12
2021
667
0.410
Why?
Doxorubicin
8
2018
242
0.410
Why?
Signal Transduction
12
2020
1699
0.410
Why?
Bone Diseases
3
2012
92
0.400
Why?
Thrombosis
4
2012
252
0.390
Why?
Neoplasms, Second Primary
2
2024
75
0.390
Why?
T-Lymphocytes
10
2024
316
0.380
Why?
Central Nervous System Neoplasms
2
2004
69
0.370
Why?
Myeloablative Agonists
5
2014
32
0.370
Why?
Bone Marrow
7
2022
361
0.370
Why?
Oligopeptides
2
2013
92
0.360
Why?
Transplantation, Homologous
6
2004
149
0.360
Why?
Osteoblasts
4
2007
473
0.350
Why?
Risk Factors
18
2018
3922
0.350
Why?
Hematopoietic Stem Cells
2
2010
188
0.350
Why?
Meta-Analysis as Topic
2
2015
39
0.340
Why?
Salvage Therapy
9
2012
136
0.340
Why?
Granulocyte Colony-Stimulating Factor
2
2008
64
0.340
Why?
Tumor Microenvironment
3
2024
246
0.340
Why?
Mice
19
2024
5877
0.330
Why?
Bone Marrow Transplantation
5
2007
110
0.330
Why?
Enzyme Inhibitors
2
2019
371
0.330
Why?
Membrane Proteins
4
2017
328
0.320
Why?
Ultrasonography, Doppler
2
2007
41
0.320
Why?
Prospective Studies
9
2019
2424
0.310
Why?
Remission Induction
10
2008
218
0.310
Why?
Cell Cycle Proteins
2
2021
167
0.310
Why?
Neoplasm, Residual
4
2022
170
0.310
Why?
Myelodysplastic Syndromes
4
2007
85
0.310
Why?
B-Lymphocytes
4
2021
180
0.300
Why?
Aged, 80 and over
12
2025
3382
0.300
Why?
Waldenstrom Macroglobulinemia
3
2018
38
0.300
Why?
Lymphoma, B-Cell
3
2021
61
0.290
Why?
Neovascularization, Pathologic
1
2009
158
0.290
Why?
Immunosuppressive Agents
3
2005
249
0.290
Why?
Bone Neoplasms
1
2010
184
0.290
Why?
Killer Cells, Natural
4
2024
112
0.280
Why?
Brain Diseases, Metabolic
1
2007
5
0.270
Why?
Dose-Response Relationship, Drug
6
2016
1368
0.270
Why?
Chromosome Deletion
3
2008
139
0.270
Why?
Proteasome Endopeptidase Complex
4
2018
138
0.270
Why?
Hyperammonemia
1
2007
23
0.270
Why?
Amyloidosis
2
2007
85
0.260
Why?
Farnesyltranstransferase
1
2006
4
0.260
Why?
Thrombophilia
4
2009
18
0.260
Why?
Research Design
1
2009
367
0.260
Why?
Small Molecule Libraries
2
2019
66
0.260
Why?
Hemostasis
1
2007
55
0.260
Why?
Peripheral Blood Stem Cell Transplantation
4
2014
59
0.260
Why?
Bone and Bones
1
2010
492
0.250
Why?
Flow Cytometry
6
2018
397
0.250
Why?
Sirolimus
1
2006
72
0.250
Why?
Immunotherapy, Adoptive
4
2024
155
0.250
Why?
Cell Survival
8
2018
596
0.250
Why?
Gastrointestinal Neoplasms
1
2006
42
0.240
Why?
Caspases
1
2006
102
0.240
Why?
In Situ Hybridization, Fluorescence
6
2016
262
0.240
Why?
Diploidy
2
2004
25
0.230
Why?
beta 2-Microglobulin
5
2008
39
0.230
Why?
Antibody Formation
1
2005
51
0.230
Why?
Religion
1
2005
61
0.230
Why?
Activated Protein C Resistance
4
2011
10
0.220
Why?
Case-Control Studies
10
2018
1193
0.220
Why?
Aneuploidy
1
2004
18
0.220
Why?
Enoxaparin
1
2004
31
0.220
Why?
Attitude to Health
1
2005
191
0.210
Why?
Ubiquitination
2
2021
57
0.210
Why?
Adaptation, Psychological
1
2005
229
0.210
Why?
Osteolysis
2
2022
74
0.210
Why?
Multivariate Analysis
5
2008
600
0.210
Why?
Cancer Vaccines
3
2010
78
0.200
Why?
Cisplatin
6
2009
284
0.200
Why?
Pyrimidines
3
2015
198
0.200
Why?
Cell Communication
2
2006
72
0.200
Why?
Randomized Controlled Trials as Topic
4
2012
608
0.200
Why?
Blood Coagulation
1
2003
60
0.200
Why?
Mice, Inbred NOD
6
2020
90
0.200
Why?
Critical Illness
1
2005
310
0.190
Why?
Antigens, CD34
1
2003
73
0.190
Why?
Cytogenetic Analysis
6
2007
79
0.190
Why?
Parathyroid Hormone
3
2010
149
0.190
Why?
Graft vs Host Disease
5
2010
88
0.190
Why?
Leukemia, Myeloid
1
2002
40
0.190
Why?
Cyclophosphamide
4
2003
173
0.190
Why?
STAT3 Transcription Factor
4
2015
86
0.190
Why?
Bone Resorption
2
2022
302
0.190
Why?
Kidney
1
2007
713
0.190
Why?
Chromosome Disorders
1
2002
32
0.180
Why?
Time Factors
9
2016
2970
0.180
Why?
Etoposide
5
2009
71
0.180
Why?
Hypothyroidism
1
2002
57
0.180
Why?
Logistic Models
5
2018
925
0.180
Why?
Cyclin-Dependent Kinase Inhibitor p21
2
2015
68
0.180
Why?
Chromosomes, Human, Pair 1
3
2006
95
0.180
Why?
Antibodies, Bispecific
1
2022
88
0.170
Why?
Neoplasm Recurrence, Local
4
2024
630
0.170
Why?
Neoplasms
2
2009
1288
0.160
Why?
DNA-Binding Proteins
2
2020
424
0.160
Why?
Cytotoxicity, Immunologic
3
2012
56
0.160
Why?
Xenograft Model Antitumor Assays
5
2019
216
0.160
Why?
Glucuronidase
2
2018
47
0.160
Why?
Predictive Value of Tests
5
2009
939
0.160
Why?
Hematologic Neoplasms
2
2016
100
0.150
Why?
Proto-Oncogene Proteins c-bcl-2
2
2013
128
0.150
Why?
Osteoclasts
4
2022
427
0.150
Why?
Cytokines
4
2007
621
0.150
Why?
Syndecan-1
3
2017
73
0.150
Why?
Kaplan-Meier Estimate
6
2015
482
0.150
Why?
Healthcare Disparities
1
2022
296
0.150
Why?
Hydrocarbons, Aromatic
1
2018
2
0.150
Why?
Drug Tolerance
1
2018
60
0.150
Why?
Solvents
1
2018
33
0.150
Why?
T-Lymphocytes, Cytotoxic
3
2010
65
0.140
Why?
Pyridines
1
2019
134
0.140
Why?
Jehovah's Witnesses
1
2018
6
0.140
Why?
Dendritic Cells
3
2010
133
0.140
Why?
Vincristine
3
2003
88
0.140
Why?
Cell Differentiation
4
2022
670
0.140
Why?
Platelet Count
3
2008
76
0.140
Why?
CDC2-CDC28 Kinases
2
2015
11
0.140
Why?
Iron
2
2017
130
0.140
Why?
Risk Assessment
5
2023
1339
0.140
Why?
Occupational Diseases
1
2018
85
0.130
Why?
Interleukin-6
2
2018
274
0.130
Why?
Arsenicals
2
2010
15
0.130
Why?
Pyruvate Kinase
1
2017
7
0.130
Why?
Occupational Exposure
1
2018
109
0.130
Why?
Mice, SCID
5
2018
178
0.130
Why?
Ascorbic Acid
1
2017
25
0.130
Why?
Drug Combinations
1
2017
134
0.130
Why?
Oxides
2
2010
21
0.130
Why?
RNA Splicing
1
2017
41
0.130
Why?
Anthropometry
1
2017
101
0.130
Why?
Transcription Factors
1
2020
564
0.130
Why?
Immunotherapy
4
2006
240
0.130
Why?
Glycolysis
1
2017
72
0.130
Why?
Factor V
3
2011
10
0.120
Why?
Immunoglobulin lambda-Chains
1
2016
15
0.120
Why?
Immunoglobulin kappa-Chains
1
2016
22
0.120
Why?
Tumor Cells, Cultured
6
2019
445
0.120
Why?
Fibrinolytic Agents
2
2007
131
0.120
Why?
Incidence
3
2009
1070
0.120
Why?
MicroRNAs
1
2020
385
0.120
Why?
Leukocytes, Mononuclear
2
2014
122
0.120
Why?
Reproductive History
1
2015
4
0.120
Why?
Oncolytic Virotherapy
1
2015
21
0.120
Why?
Hormone Replacement Therapy
1
2015
21
0.120
Why?
Cyclopentanes
1
2015
12
0.120
Why?
Cell Adhesion Molecules
1
2015
88
0.120
Why?
Ubiquitins
1
2015
18
0.120
Why?
Hemorrhage
2
2007
222
0.120
Why?
Postmenopause
1
2015
83
0.110
Why?
Receptors, Cell Surface
1
2015
110
0.110
Why?
Cation Transport Proteins
1
2015
26
0.110
Why?
Aldehyde Dehydrogenase
1
2014
24
0.110
Why?
NF-kappa B
3
2018
329
0.110
Why?
Intestines
1
2016
154
0.110
Why?
Drug Monitoring
1
2015
82
0.110
Why?
Protein-Tyrosine Kinases
1
2015
87
0.110
Why?
Leukapheresis
1
2014
19
0.110
Why?
Translocation, Genetic
3
2005
265
0.110
Why?
Transplantation Chimera
3
2003
16
0.110
Why?
Myeloma Proteins
2
2020
26
0.110
Why?
Gene Deletion
3
2004
274
0.110
Why?
Antibodies
2
2024
148
0.110
Why?
Polymorphism, Single Nucleotide
1
2016
504
0.100
Why?
Receptor, Parathyroid Hormone, Type 1
1
2013
25
0.100
Why?
Veratrum Alkaloids
1
2013
5
0.100
Why?
Body Mass Index
1
2017
699
0.100
Why?
Multidrug Resistance-Associated Proteins
1
2013
17
0.100
Why?
Isoxazoles
1
2013
15
0.100
Why?
Biopsy
2
2006
599
0.100
Why?
Sulfones
1
2013
24
0.100
Why?
Hedgehog Proteins
1
2013
34
0.100
Why?
Cystatin M
2
2024
17
0.100
Why?
Itraconazole
1
2013
38
0.100
Why?
Genetic Predisposition to Disease
1
2016
528
0.100
Why?
Metaphase
3
2008
46
0.100
Why?
Intercellular Adhesion Molecule-1
1
2013
59
0.100
Why?
Carrier Proteins
2
2017
316
0.100
Why?
Renal Insufficiency
3
2009
110
0.100
Why?
B-Cell Maturation Antigen
2
2024
92
0.100
Why?
Wnt Proteins
1
2013
102
0.100
Why?
Risk
2
2011
312
0.100
Why?
Infusions, Intravenous
2
2003
218
0.100
Why?
Viremia
1
2012
23
0.090
Why?
Drug Delivery Systems
2
2005
146
0.090
Why?
Chromosomes, Human, Pair 11
2
2002
55
0.090
Why?
Cytomegalovirus Infections
1
2012
36
0.090
Why?
Radiopharmaceuticals
2
2021
199
0.090
Why?
Clinical Trials, Phase II as Topic
1
2012
47
0.090
Why?
Fluorodeoxyglucose F18
2
2021
181
0.090
Why?
Clinical Trials, Phase III as Topic
1
2012
48
0.090
Why?
Phosphorylation
2
2020
523
0.090
Why?
Receptors, KIR
2
2008
11
0.090
Why?
Medical Oncology
1
2012
96
0.090
Why?
Reoperation
2
2004
463
0.090
Why?
Alcohol Drinking
1
2013
236
0.090
Why?
Ligands
2
2009
206
0.090
Why?
Drug Evaluation, Preclinical
1
2012
141
0.090
Why?
Inflammation
1
2016
641
0.090
Why?
Age Factors
3
2005
1125
0.090
Why?
Smoking
1
2014
516
0.090
Why?
Receptors, TNF-Related Apoptosis-Inducing Ligand
1
2010
6
0.090
Why?
Tretinoin
2
2009
53
0.090
Why?
TNF-Related Apoptosis-Inducing Ligand
1
2010
20
0.090
Why?
Recombinant Proteins
2
2010
492
0.080
Why?
Janus Kinase 1
1
2010
16
0.080
Why?
Macrophages
1
2013
360
0.080
Why?
Antineoplastic Agents, Hormonal
2
2007
53
0.080
Why?
Down-Regulation
2
2010
343
0.080
Why?
MAP Kinase Kinase 1
1
2010
23
0.080
Why?
Cyclin-Dependent Kinases
1
2010
26
0.080
Why?
Authorship
1
2010
11
0.080
Why?
Neoplasm Staging
3
2015
766
0.080
Why?
Extracellular Signal-Regulated MAP Kinases
1
2010
83
0.080
Why?
Bone Density Conservation Agents
1
2010
75
0.080
Why?
Conflict of Interest
1
2010
24
0.080
Why?
Drug Industry
1
2010
39
0.080
Why?
Diphosphonates
1
2010
92
0.080
Why?
Disclosure
1
2010
40
0.080
Why?
Mice, Transgenic
3
2021
560
0.080
Why?
Chromosome Banding
2
2006
24
0.080
Why?
Leukocyte Count
2
2014
72
0.080
Why?
Plasmacytoma
2
2011
43
0.080
Why?
Periodicals as Topic
1
2010
62
0.080
Why?
Oligonucleotide Array Sequence Analysis
5
2014
411
0.080
Why?
Magnetic Resonance Imaging
3
2007
1518
0.080
Why?
Maximum Tolerated Dose
2
2009
39
0.080
Why?
Cell Cycle
2
2010
237
0.080
Why?
Cryoglobulinemia
1
2008
13
0.070
Why?
Blotting, Western
3
2015
588
0.070
Why?
Vascular Endothelial Growth Factor A
1
2009
187
0.070
Why?
Cytogenetics
1
2008
23
0.070
Why?
Prednisone
2
2009
102
0.070
Why?
Pulmonary Embolism
1
2009
83
0.070
Why?
Neutrophils
2
2014
146
0.070
Why?
Sulfonamides
1
2009
132
0.070
Why?
Polyethylene Glycols
1
2008
91
0.070
Why?
Reverse Transcriptase Polymerase Chain Reaction
3
2015
580
0.070
Why?
Immunophenotyping
2
2007
117
0.070
Why?
Adoptive Transfer
1
2007
29
0.070
Why?
Hemoglobins
1
2008
111
0.070
Why?
Heparin, Low-Molecular-Weight
1
2007
22
0.070
Why?
CD8-Positive T-Lymphocytes
2
2024
128
0.070
Why?
Histocompatibility Antigens Class I
1
2007
47
0.070
Why?
Phlebography
1
2007
55
0.070
Why?
Fibrinolysis
1
2007
6
0.070
Why?
Blood Coagulation Factors
1
2007
17
0.070
Why?
Ammonia
1
2007
86
0.070
Why?
Serum Albumin
2
2008
57
0.060
Why?
Chi-Square Distribution
1
2007
292
0.060
Why?
Cell Membrane
1
2007
231
0.060
Why?
Brain
2
2007
1311
0.060
Why?
Biomedical Research
1
2010
262
0.060
Why?
Drug Administration Schedule
2
2006
374
0.060
Why?
Osteoprotegerin
1
2006
53
0.060
Why?
Models, Genetic
1
2006
173
0.060
Why?
Guanosine
1
2006
7
0.060
Why?
Antibiotics, Antineoplastic
1
2006
79
0.060
Why?
Sex Factors
3
2016
731
0.060
Why?
Femur Head Necrosis
1
2005
17
0.060
Why?
Renal Dialysis
1
2007
190
0.060
Why?
Survivors
1
2006
118
0.060
Why?
Guanosine Triphosphate
1
2004
15
0.060
Why?
Karyotyping
1
2005
78
0.060
Why?
Neovascularization, Physiologic
1
2005
87
0.060
Why?
Gene Duplication
1
2005
16
0.060
Why?
Oncogene Proteins, Fusion
1
2005
60
0.060
Why?
Tissue Donors
2
2003
124
0.060
Why?
ROC Curve
1
2025
250
0.060
Why?
Kidney Transplantation
1
2007
196
0.060
Why?
Proteolysis
2
2015
102
0.050
Why?
Thrombophlebitis
1
2004
18
0.050
Why?
Genomic Instability
1
2005
89
0.050
Why?
Tomography, Emission-Computed
1
2004
53
0.050
Why?
Ferritins
1
2024
36
0.050
Why?
RNA Interference
2
2015
185
0.050
Why?
Neoplastic Cells, Circulating
1
2004
34
0.050
Why?
Myeloid Progenitor Cells
1
2023
15
0.050
Why?
X-Ray Microtomography
1
2024
77
0.050
Why?
Chromatography, High Pressure Liquid
1
2004
335
0.050
Why?
Patient Selection
1
2005
265
0.050
Why?
Stem Cell Factor
1
2003
7
0.050
Why?
Discitis
1
2003
10
0.050
Why?
Confidence Intervals
1
2003
159
0.050
Why?
Lymphocyte Transfusion
1
2003
10
0.050
Why?
Probability
1
2003
171
0.050
Why?
Interferons
1
2002
37
0.050
Why?
Anxiety
1
2005
301
0.050
Why?
TNF Receptor-Associated Factor 3
1
2022
13
0.050
Why?
Cell Count
1
2003
143
0.050
Why?
Cyclosporine
1
2003
67
0.050
Why?
Transcriptome
1
2025
363
0.050
Why?
Drug Therapy, Combination
2
2017
399
0.050
Why?
Geography
1
2022
65
0.050
Why?
Thyroid Function Tests
1
2002
27
0.050
Why?
Blood Group Incompatibility
1
2002
4
0.050
Why?
Tacrolimus
1
2003
60
0.050
Why?
Stromal Cells
1
2002
77
0.050
Why?
ABO Blood-Group System
1
2002
15
0.050
Why?
Administration, Oral
1
2003
453
0.050
Why?
Thyrotropin
1
2002
49
0.050
Why?
Leukemia, Promyelocytic, Acute
1
2002
11
0.050
Why?
Drug Interactions
1
2002
201
0.050
Why?
Fatal Outcome
1
2002
192
0.050
Why?
Genomics
1
2023
265
0.040
Why?
Chromosome Mapping
3
2006
149
0.040
Why?
Cell Division
1
2002
288
0.040
Why?
Cells, Cultured
1
2005
1568
0.040
Why?
RANK Ligand
1
2022
187
0.040
Why?
Graft Survival
1
2002
158
0.040
Why?
Acute Disease
1
2002
386
0.040
Why?
Tomography, X-Ray Computed
1
2006
1148
0.040
Why?
Cluster Analysis
3
2006
236
0.040
Why?
Young Adult
3
2015
4307
0.040
Why?
Pain
1
2003
353
0.040
Why?
Depression
1
2005
603
0.040
Why?
Neoplasm Transplantation
1
2020
86
0.040
Why?
Odds Ratio
2
2016
564
0.040
Why?
Staphylococcal Infections
1
2003
272
0.040
Why?
3' Untranslated Regions
1
2020
55
0.040
Why?
Postoperative Complications
1
2007
1071
0.040
Why?
Positron-Emission Tomography
1
2021
297
0.040
Why?
Antigens, CD
2
2015
215
0.040
Why?
Crystallography, X-Ray
1
2019
156
0.040
Why?
Mice, Nude
1
2019
231
0.040
Why?
Protein Conformation
1
2019
177
0.040
Why?
Bone Marrow Cells
2
2015
189
0.040
Why?
Coculture Techniques
2
2012
142
0.040
Why?
Mice, Inbred BALB C
1
2019
307
0.040
Why?
Receptors, Interleukin-6
1
2018
23
0.040
Why?
Antigens, CD19
1
2018
28
0.040
Why?
Microarray Analysis
1
2018
69
0.040
Why?
Disease Management
1
2020
185
0.040
Why?
Drug Resistance
1
2018
68
0.040
Why?
Interferon-gamma
2
2010
172
0.040
Why?
Protein Stability
1
2018
45
0.040
Why?
Gene Knockdown Techniques
1
2018
108
0.040
Why?
Epidemiologic Methods
2
2008
46
0.030
Why?
Aerobiosis
1
2017
13
0.030
Why?
Cross-Sectional Studies
1
2022
1665
0.030
Why?
Microfilament Proteins
1
2017
44
0.030
Why?
HLA-A Antigens
2
2007
11
0.030
Why?
Transplantation, Heterologous
1
2017
78
0.030
Why?
Calcium-Binding Proteins
1
2017
57
0.030
Why?
Thyroid Hormones
1
2017
22
0.030
Why?
Polycomb Repressive Complex 1
1
2016
3
0.030
Why?
Transmembrane Activator and CAML Interactor Protein
1
2016
6
0.030
Why?
Vaccination
2
2010
296
0.030
Why?
Proto-Oncogene Proteins c-myc
1
2017
53
0.030
Why?
Genetic Loci
1
2016
48
0.030
Why?
Protein Binding
1
2018
665
0.030
Why?
Antibodies, Neoplasm
2
2006
27
0.030
Why?
Mice, Inbred ICR
1
2016
25
0.030
Why?
Mice, Knockout
1
2018
893
0.030
Why?
Microscopy, Electron, Transmission
1
2015
69
0.030
Why?
Reoviridae
1
2015
25
0.030
Why?
Tumor Burden
1
2016
133
0.030
Why?
Genome-Wide Association Study
1
2016
184
0.030
Why?
ras Proteins
1
2015
63
0.030
Why?
Repressor Proteins
1
2016
150
0.030
Why?
Receptors, Transferrin
1
2015
16
0.030
Why?
Disease Models, Animal
2
2013
1467
0.030
Why?
Side-Population Cells
1
2015
3
0.030
Why?
RNA, Messenger
2
2010
1135
0.030
Why?
Models, Biological
1
2018
731
0.030
Why?
Family
1
2016
170
0.030
Why?
Lentivirus
1
2015
17
0.030
Why?
Retinal Dehydrogenase
1
2014
10
0.030
Why?
Adenine
1
2015
30
0.030
Why?
Cyclin B
1
2014
4
0.030
Why?
CDC2 Protein Kinase
1
2014
15
0.030
Why?
Molecular Targeted Therapy
1
2016
132
0.030
Why?
G2 Phase Cell Cycle Checkpoints
1
2014
9
0.030
Why?
Reactive Oxygen Species
1
2017
421
0.030
Why?
Portraits as Topic
1
2014
2
0.030
Why?
Cell Lineage
1
2014
87
0.030
Why?
Drug Synergism
1
2014
148
0.030
Why?
Mitosis
1
2014
87
0.030
Why?
beta Catenin
1
2015
103
0.030
Why?
Piperidines
1
2015
96
0.030
Why?
Drug Screening Assays, Antitumor
1
2014
136
0.030
Why?
Pyrazoles
1
2015
113
0.030
Why?
Cell Movement
1
2015
273
0.030
Why?
Proportional Hazards Models
2
2006
439
0.030
Why?
Patient Safety
1
2014
102
0.030
Why?
Peptide Library
1
2013
16
0.030
Why?
Receptors, IgG
1
2013
24
0.020
Why?
Adolescent
2
2014
6681
0.020
Why?
Membrane Glycoproteins
2
2006
238
0.020
Why?
Chromosomal Instability
1
2013
16
0.020
Why?
Epitopes
1
2013
62
0.020
Why?
Antibodies, Monoclonal, Murine-Derived
1
2012
47
0.020
Why?
Protein Kinase Inhibitors
1
2014
225
0.020
Why?
Immunoglobulin M
1
2012
60
0.020
Why?
Interleukin Receptor Common gamma Subunit
1
2012
7
0.020
Why?
NK Cell Lectin-Like Receptor Subfamily K
1
2012
8
0.020
Why?
Cytomegalovirus
1
2012
30
0.020
Why?
Viral Load
1
2012
80
0.020
Why?
Interleukin-2
1
2012
68
0.020
Why?
Virus Activation
1
2012
39
0.020
Why?
Peripheral Nervous System Diseases
1
2012
58
0.020
Why?
Immunoenzyme Techniques
1
2012
135
0.020
Why?
Arkansas
2
2008
2016
0.020
Why?
Viper Venoms
1
2011
6
0.020
Why?
Lymphocyte Activation
1
2012
160
0.020
Why?
Asymptomatic Diseases
1
2011
38
0.020
Why?
Neoadjuvant Therapy
1
2012
123
0.020
Why?
Protein C
1
2011
20
0.020
Why?
Chemotherapy, Adjuvant
1
2011
121
0.020
Why?
Interferon Regulatory Factor-1
1
2010
14
0.020
Why?
Cell Growth Processes
1
2010
24
0.020
Why?
Antiviral Agents
1
2012
177
0.020
Why?
Immunoglobulin Idiotypes
1
2010
5
0.020
Why?
CD40 Ligand
1
2010
14
0.020
Why?
Hypersensitivity, Delayed
1
2010
18
0.020
Why?
Interleukin-4
1
2010
40
0.020
Why?
Immunity, Cellular
1
2010
62
0.020
Why?
Adjuvants, Immunologic
1
2010
52
0.020
Why?
Diagnosis, Differential
2
2004
1031
0.020
Why?
Mutation
1
2015
1318
0.020
Why?
RNA, Small Interfering
1
2010
215
0.020
Why?
Physician's Role
1
2010
50
0.020
Why?
Education, Medical, Continuing
1
2010
72
0.020
Why?
Practice Guidelines as Topic
1
2012
494
0.020
Why?
Hyperhomocysteinemia
1
2009
29
0.020
Why?
Protein Isoforms
1
2009
124
0.020
Why?
Indazoles
1
2009
47
0.020
Why?
Cytotoxicity Tests, Immunologic
1
2008
26
0.020
Why?
Safety
1
2009
80
0.020
Why?
Algorithms
1
2012
663
0.020
Why?
Vasculitis
1
2008
28
0.020
Why?
Ploidies
1
2008
10
0.020
Why?
Haplotypes
1
2008
95
0.020
Why?
Double-Blind Method
1
2009
718
0.020
Why?
Twins
1
2007
33
0.020
Why?
Age Distribution
1
2007
174
0.020
Why?
C-Reactive Protein
1
2008
152
0.020
Why?
Multigene Family
1
2006
49
0.020
Why?
Creatinine
1
2007
158
0.020
Why?
Blood Proteins
1
2007
84
0.020
Why?
Partial Thromboplastin Time
1
2006
14
0.020
Why?
Cyclin D
1
2006
18
0.020
Why?
Syndecans
1
2006
37
0.020
Why?
Cyclins
1
2006
38
0.020
Why?
Heterozygote
1
2006
91
0.020
Why?
RNA, Neoplasm
1
2006
45
0.020
Why?
Proteoglycans
1
2006
86
0.020
Why?
Amiloride
1
2005
7
0.020
Why?
HLA-A2 Antigen
1
2005
11
0.020
Why?
Cell Line
1
2008
1018
0.020
Why?
Transduction, Genetic
1
2005
44
0.020
Why?
Radiography
1
2007
472
0.010
Why?
Leukemia, Myeloid, Acute
1
2007
201
0.010
Why?
Data Interpretation, Statistical
1
2006
168
0.010
Why?
Neoplasms, Experimental
1
2006
112
0.010
Why?
Sensitivity and Specificity
1
2007
871
0.010
Why?
Interferon-alpha
1
2005
52
0.010
Why?
Monocytes
1
2005
126
0.010
Why?
Databases, Factual
1
2007
714
0.010
Why?
Clone Cells
1
2004
76
0.010
Why?
Antibodies, Monoclonal, Humanized
1
2005
232
0.010
Why?
Monosomy
1
2003
5
0.010
Why?
Trisomy
1
2003
35
0.010
Why?
Fibroblasts
1
2005
358
0.010
Why?
History, 21st Century
1
2003
58
0.010
Why?
History, 20th Century
1
2003
95
0.010
Why?
Interphase
1
2003
9
0.010
Why?
Plasmapheresis
1
2003
12
0.010
Why?
Back Pain
1
2003
39
0.010
Why?
United States
1
2013
5168
0.010
Why?
Perforin
1
2002
12
0.010
Why?
Pore Forming Cytotoxic Proteins
1
2002
11
0.010
Why?
Anemia
1
2003
75
0.010
Why?
Cohort Studies
1
2006
1541
0.010
Why?
Antigen Presentation
1
2002
26
0.010
Why?
Red-Cell Aplasia, Pure
1
2002
7
0.010
Why?
Prevalence
1
2005
1013
0.010
Why?
Quality Assurance, Health Care
1
2003
147
0.010
Why?
Erythrocyte Transfusion
1
2002
51
0.010
Why?
Cell Culture Techniques
1
2002
97
0.010
Why?
DNA, Neoplasm
1
2002
146
0.010
Why?
Graft Rejection
1
2002
172
0.010
Why?
Kidney Diseases
1
2003
229
0.010
Why?
Anti-Bacterial Agents
1
2003
796
0.010
Why?
Tricot's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description